|
AVTX | Avalo Therapeutics, Inc. |
|
|
AVTX | Avalo Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.03 |
| Leverage | 26.82% |
| Market Cap | $ 3.6B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -98.9m |
| Margin | -5775.71% |
None